I think a little exposure to the small side of the market can be a good thing for a portfolio.
This is because even blue chip companies such as Ramsay Health Care Limited (ASX: RHC) and TPG Telecom Ltd (ASX: TPM) were small caps at one stage.
Anyone that bought their shares at that point and held onto them until today will have generated incredible returns.
And while not all small cap shares will live up to their potential, there are a few that I feel have a good chance of doing so.
The three small ASX cap shares listed below are ones that I believe have enormous potential:
Audinate Group Limited (ASX: AD8)
The first small cap share to consider is Audinate. It is a digital audio-visual networking technologies provider which has delivered very strong sales growth in recent years. This is thanks to the increasing demand for its flagship Dante product. This award-winning audio over IP networking solution is being used widely across the professional live sound, commercial installation, broadcast, and recording industries globally.
Opthea Ltd (ASX: OPT)
Another small cap to consider is Opthea. It is a developer of novel biologic therapies for the treatment of eye diseases. I’m a big fan of Opthea due to the enormous potential of its OPT-302 combination therapy. This year the company’s Phase 2b study delivered exceptional results. Given that the current standard of care treatments for wet age-related macular degeneration and diabetic macular edema had sales of over US$3.7 billion and US$6.2 billion in 2018, OPT-302 could be a real cash cow for the company if all goes to plan.
Serko Ltd (ASX: SKO)
A final small cap share to consider buying is Serko. It is a leading online travel booking and expense management provider. It has been an impressive performer over the last couple of years and has continued this positive form in FY 2020 with further strong revenue growth year to date. It also recently raised NZ$45 million to accelerate its growth. A cornerstone investor in this capital raising was travel booking giant Booking.com.
The post 3 exciting small cap ASX shares to buy for 2020 appeared first on Motley Fool Australia.
And these stellar growth shares could also be high quality options for investors in 2020. I'm tipping them as market beaters next year.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AUDINATEGL FPO and Serko Ltd. The Motley Fool Australia has recommended AUDINATEGL FPO, Ramsay Health Care Limited, and Serko Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019